<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>OAR@UM Collection:</title>
  <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/77206" />
  <subtitle />
  <id>https://www.um.edu.mt/library/oar/handle/123456789/77206</id>
  <updated>2026-04-11T01:10:34Z</updated>
  <dc:date>2026-04-11T01:10:34Z</dc:date>
  <entry>
    <title>Interactions between valproate and olanzapine/quetiapine in bipolar disorder</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/77988" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/77988</id>
    <updated>2021-07-06T08:20:21Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Title: Interactions between valproate and olanzapine/quetiapine in bipolar disorder
Abstract: A combination of valproate with an atypical antipsychotic provides synergistic mood &#xD;
stabilizing, anti-depressant and anti-psychotic action in bipolar and schizoaffective &#xD;
disorders. Reports of rare, but serious, adverse drug reactions occurring on the addition of &#xD;
valproic acid to olanzapine and quetiapine monotherapy indicate a possible &#xD;
pharmacokinetic or pharmacodynamic drug-drug interaction. Some studies have shown &#xD;
that valproate affects drug metabolising enzymes responsible for the metabolism of &#xD;
olanzapine and quetiapine, resulting in altered antipsychotic plasmsa concentrations and &#xD;
interfering with clinical efficacy and toxicity. The aim of this study was thus to recruit &#xD;
patients on a combination of valproate/olanzapine or valproate/quetiapine to assess the &#xD;
possible effect of valproate on the plasma concentrations of these antipsychotics by &#xD;
comparing the drug concentrations in these patients with control groups of patients on &#xD;
quetiapine or olanzapine monotherapy.
Description: M.SC.PHARMACOLOGY</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Identifying compounds that enhance the resilience of isolated neuronal mitochondria against dysfunction induced by Aß42 and tau oligomers</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/77918" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/77918</id>
    <updated>2021-07-06T08:06:11Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Title: Identifying compounds that enhance the resilience of isolated neuronal mitochondria against dysfunction induced by Aß42 and tau oligomers
Abstract: The oligomeric intraneuronal accumulation of amyloid beta AB42 (AB42 ) and Tau &#xD;
has been directly linked to Alzheimer's Disease (AD) pathology and progression. &#xD;
In particular, mounting evidence indicates that oligomer-induced mitochondrial &#xD;
abnormalities are early occurrences, preceding neurological pathology and &#xD;
clinical symptoms characteristic of AD. Perforation of mitochondrial membranes &#xD;
leads to the release of pro-apoptotic proteins such as cytochrome c into the &#xD;
cellular cytosol, triggering neuronal apoptosis. The main aims of the study were to &#xD;
determine any effects of Ab42 and Tau aggregates on mitochondrial membranes &#xD;
and subsequently identify mitochondrial-protective compounds. The rationale &#xD;
behind the study was to gain further insight as to the mechanisms involved in &#xD;
AbTau induced mito-toxicity, and identify potential candidates for effective &#xD;
mitochondrial drugs in AD.
Description: M.SC.PHARMACOLOGY</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Community pharmacists; approach to pharmacological management of Alzheimer's disease in Malta and Gozo</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/77908" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/77908</id>
    <updated>2021-07-05T05:28:29Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Title: Community pharmacists; approach to pharmacological management of Alzheimer's disease in Malta and Gozo
Abstract: In view of the projected rise in the Maltese elderly population in the next 20 years and the &#xD;
inevitable associated increase in the prevalence and incidence of neurological illnesses, &#xD;
healthcare professionals need to have a better understanding of Alzheimer's disease (AD), &#xD;
the most common form of dementia Community pharmacists are nowadays being &#xD;
integrated in the optimization of service provision to AD patients and their families&#xD;
however, little is known about how knowledgeable pharmacists are about AD.
Description: M.SC.PHARMACOLOGY</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Doping in sport : the Maltese scenario</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/77744" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/77744</id>
    <updated>2021-06-28T08:10:56Z</updated>
    <published>2012-01-01T00:00:00Z</published>
    <summary type="text">Title: Doping in sport : the Maltese scenario
Abstract: The use of substances to enhance performance is common amongst sportspersons &#xD;
of all categories and ages. While some of these substances are legal, others are illicit &#xD;
and some sportspersons still use them, despite the possible risks. World-wide the &#xD;
World Anti-Doping Agency (WADA) is responsible for the research, education and &#xD;
development of anti-doping policies, rules and regulations. The World Anti-Doping &#xD;
Code (W ADC) is a document which harmonises anti-doping policies internationally. &#xD;
Malta was declared fully compliant by WADA only early in 2012, although doping &#xD;
tests had been carried out on a federation basis by some sports associations &#xD;
previously. Thus, while the extent of doping in sport in Malta is not known, positive &#xD;
results obtained from these tests indicate that this may be a reality.
Description: M.SC.PHARMACOLOGY</summary>
    <dc:date>2012-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

